Foundation Event

RHO Day Webinar

Friday, November 6, 2026, 10:00 a.m. – 12:15 p.m. (EDT)

Join the global RHO-adRP community for a live, interactive virtual gathering for patients, families, clinicians, and industry partners.
Get updates on Foundation Event

Location

Virtual

Virtual

RSVP

For questions, contact Grace Warner at GraceWarner@GundVisionFund.org.

This session brings together clinical experts, genetic specialists, and biotech pioneers to explore Rhodopsin mediated autosomal dominant retinitis pigmentosa.

Key Topics

  • Disease progression & the patient journey
  • Genetic testing & autosomal-dominant inheritance
  • Clinical trial participation & patient resources
  • Emerging industry research pipelines
  • Live audience Q&A

 

Featured Speakers

Jason Comander, MD, PhD (Director, Inherited Retinal Disorders Service, Mass Eye & Ear) – RHO disease overview

Kari Branham, MS, CGC (Director of Ophthalmic Genetic Counseling, Kellogg Eye Center, Univ. of Michigan) – Genetics & testing

Mary & Lara Findlay – RHO-adRP family perspective

Todd Durham, PhD (SVP, Clinical & Outcomes Research, Foundation Fighting Blindness) – Clinical trials & resources

Alicia Kemble, PhD (Principal, Gund Vision Fund) – Moderator

Industry Pipeline Presenters

Matthew Albert, MD, PhD – VP, Early Clinical Development, Octant

Sally Tucker, PhD – Chief Medical Officer, Opus Genetics

Kali Stasi, MD, PhD – Chief Medical Officer, SparingVision

Beth Scott, OD, MS – VP, Clinical Development, Ocugen

Emily Brown, PhD – Associate Director, Clinical Development, Ophthalmology, BlueRock Therapeutics

Register to receive your meeting link and connect with the global community. All registrants receive session recordings and materials post-event.